Definitive Contract HHSN268201100034C
Award Date
6/15/11
Potential Completion Date
12/14/11
Potential Value
$149K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Aphios Corp
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Woburn, MA 01801, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
<p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $279,113, was awarded to Gwathmey, Inc. on August 26, 2009 for biomedical (applied/exploratory) research. The contract has a firm fixed price pricing type and a completion date of September 30, 2010.</p>
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency of the U.S. government. The contract, valued at $224,944.00, was awarded to Sibtech, Inc. on September 8, 2014 and has a completion date of December 7, 2015. The contract aims to develop specific molecular imaging agents that can be used in combination with existing imaging modalities to detect high-risk atherosclerotic plaque. This research...
This is a $94,448 firm fixed price contract awarded by the National Center for Complementary and Integrative Health, a component of the U.S. Department of Health and Human Services, to Aphios Corp, a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development work related to the NCCAM 002 SBIR Phase I topic. The award has a total small business set-aside designation, and the contract's ultimate completion date...
<p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Prolong Pharmaceuticals, Inc. for the "Production of Pegylated Hemoglobin". The definitive, firm-fixed price contract has a ceiling value of $101,339.00 and a period of performance ending on January 31, 2009. The contract is focused on biomedical, applied/exploratory research and development.</p>
<p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Nanoshell Company, LLC, a woman-owned small business. The contract, valued at $148,235.00, is for research into using haptoglobin as a treatment to reduce complications of sickle cell disease. The contract has a firm-fixed price and was awarded on August 1, 2012, with a target completion date of March 15, 2013.</p>
This federal contract award, identified as HHSN268201200064C, was made by the National Heart Lung and Blood Institute (NHLBI), a civilian agency of the U.S. government, to HDL Apomics LLC, a small business. The $139,291.00 Firm Fixed Price contract is for "OTHER FUNCTIONS-ANTIBODY PROTEOMICS FOR MEASURING LIPOPROTEIN SUB-POPULATIONS" under the SBIR TOPIC 64 PHASE 1 - NOVEL TECHNOLOGIES FOR ASSESSING LIPOPROTEIN SUB-FRACTIONS program. The contract has a total small business set-aside...
<p>This is a federal contract award from the National Heart Lung and Blood Institute, a civilian agency, to Biomedomics, Inc., a minority-owned, for-profit manufacturer of goods, for a Small Business Innovation Research (SBIR) Program Phase I research project. The contract has a Firm Fixed Price of $99,932.00 and was awarded on December 1, 2009 with a completion date of May 31, 2010. The contract is set aside for small businesses. No additional subcontractors or context are provided.</p>
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services (HHS), to Nanoshell Company, LLC, a woman-owned small business. The contract, valued at $1,292,182, is for the development of a haptoglobin treatment to reduce complications of sickle cell disease. The contract is a definitive, firm-fixed-price contract with a period of performance ending on June...
<p>This is a $100,037.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Synzyme Technologies LLC, a for-profit limited liability company. The contract is for the production of stroma-free hemoglobin and hemoglobin-based oxygen carriers (HBOCs). It is a firm-fixed-price definitive contract with a period of performance ending on May 29, 2009.</p>
This SBIR Phase I contract was awarded by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to the small business TDA Research, Inc. The $300,000 firm fixed price contract is for developing innovations in oxygen delivery devices. The contract is a total small business set-aside. The original solicitation was part of the NIH and CDC SBIR program, which aims to stimulate innovation, strengthen the role of small businesses, and...